S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
66,000% upside on tiny biotech? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
66,000% upside on tiny biotech? (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
66,000% upside on tiny biotech? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
66,000% upside on tiny biotech? (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
66,000% upside on tiny biotech? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
66,000% upside on tiny biotech? (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
66,000% upside on tiny biotech? (Ad)
A collection of the insights Warren Buffett offered in his annual letter Saturday
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
66,000% upside on tiny biotech? (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
Here's Why Bitcoin Could Rise to $165,000 Starting Exactly On April 22, 2024. (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists

KalVista Pharmaceuticals (KALV) SEC Filings & 10K Form

$12.58
0.00 (0.00%)
(As of 02/23/2024 ET)

Recent KalVista Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/22/2024
12:22 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13D/A
02/21/2024
8:51 PM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:41 PM
Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:44 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:46 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:48 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
3:49 PM
KalVista Pharmaceuticals (Subject)
TCG Crossover GP I, LLC (Filed by)
Form SC 13D/A
02/16/2024
3:32 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:20 PM
Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
3:21 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:52 PM
KalVista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
02/14/2024
4:13 PM
KalVista Pharmaceuticals (Filer)
Form 424B5
02/13/2024
8:11 AM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:20 AM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:23 AM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:06 AM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
8:08 AM
Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:55 AM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
7:30 PM
KalVista Pharmaceuticals (Subject)
Saturn V Capital Management LP (Filed by)
Form SC 13G
02/09/2024
8:16 AM
KalVista Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2024
7:11 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
3:38 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
6:07 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
7:24 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:02 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
6:04 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
3:26 PM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
7:57 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
5:05 PM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:24 PM
KalVista Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/08/2024
3:47 PM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
3:13 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
5:44 PM
KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:16 PM
KalVista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
12/27/2023
4:12 PM
Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/14/2023
12:33 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
Form SC 13D/A
09/28/2023
3:52 PM
Cha Albert (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2023
3:53 PM
KalVista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2023
3:54 PM
KalVista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2023
3:54 PM
KalVista Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2023
3:55 PM
KalVista Pharmaceuticals (Issuer)
Treanor Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:29 PM
Cha Albert (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
5:05 PM
Cha Albert (Reporting)
KalVista Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
3:35 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2023
3:18 PM
KalVista Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/21/2023
7:05 PM
Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
7:05 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
7:06 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
7:07 PM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2023
7:09 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
3:30 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2023
8:37 PM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4/A
05/22/2023
8:39 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4/A
05/22/2023
8:40 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4/A
05/22/2023
8:33 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
8:35 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4/A
05/22/2023
8:36 PM
Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4/A
05/19/2023
8:18 PM
Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2023
8:19 PM
KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2023
8:20 PM
KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2023
8:16 PM
Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2023
8:17 PM
Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2023
4:15 PM
KalVista Pharmaceuticals (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G
03/09/2023
3:24 PM
KalVista Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:KALV) was last updated on 2/25/2024 by MarketBeat.com Staff